Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents
复制标题
DOI:
10.1007/s00125-003-1154-0
复制
发表时间:
2003-08-01
期刊:
影响因子:
8.2
通讯作者:
Mathieu, C
中科院分区:
文献类型:
--
作者:
Gysemans, C;Stoffels, K;Mathieu, C
Aims/hypothesis. High levels of inflammation locally in the graft during the initial days after transplantation can cause primary non-function (PNF) of grafted xenogeneic islets in NOD mice. The aim of this study was to explore in a model of spontaneous diabetes, the NOD mouse, the potential of anti-inflammatory agents in the prevention of PNF after xenogeneic islet transplantation.Methods. Spontaneously diabetic NOD mice were transplanted with 300 rat islets. Animals were treated with acetylsalicylic acid (AsA), rofecoxib, TGF-beta or IL-1 receptor antagonist (IL-1ra). Intra-graft expression of inflammation-related molecules was measured by real time PCR 8 h post-transplantation. At the same time point, plasma nitrite levels were measured.Results. Xenogeneic islets transplanted in control spontaneously diabetic mice resulted in PNF in 16 out of 38 mice (42%). Initial graft loss was not altered by administration of rofecoxib (30%) or TGF-beta (25%). AsA reduced the rate of rapid graft loss to 8% (p